Vigil Neuroscience (NASDAQ:VIGL) Given “Outperform” Rating at Wedbush
Wedbush restated their outperform rating on shares of Vigil Neuroscience (NASDAQ:VIGL – Free Report) in a report released on Monday,Benzinga reports. The firm currently has a $13.00 target price on the stock. Several other equities analysts also recently weighed in on VIGL. William Blair raised Vigil Neuroscience to a “strong-buy” rating in a research note […]
